Special formula may help malnourished infants with bile duct disease

NCT ID NCT06764082

Recruiting now Disease control Sponsor: Tongji Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a high-MCT (medium-chain triglyceride) formula given before and after Kasai surgery can improve growth and nutrition in infants with biliary atresia. Biliary atresia is a rare liver condition that blocks bile flow, leading to malnutrition. The trial will enroll 120 infants under 3 months old across multiple centers, comparing the special formula to standard feeding. The main goal is to see if the formula helps babies gain weight better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: high MCT formula (special medical-purpose formula food with medium-chain triglycerides)
What this could lead to: If it works, this could improve growth and nutritional status in infants with biliary atresia after surgery, potentially leading to better long-term outcomes.
What could go wrong: This is an early-stage, open-label study with only 120 participants, so results may not be conclusive. The intervention is dietary, so benefits may be modest and not apply to all infants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY ATRESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

biliary atresia Infant Nutrition Disorders nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BILIARY ATRESIA NUTRITION DISORDER, INFANT

Contacts and locations

Locations

Tongji Hospital
RECRUITING

Wuhan, Hubei, 430030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.